-
1
-
-
33644618433
-
The biology of incretin hormones
-
Drucker, D.J., (2006) The biology of incretin hormones. Cell Metabolism, 3, 153-165.
-
(2006)
Cell Metabolism
, vol.3
, pp. 153-165
-
-
Drucker, D.J.1
-
2
-
-
33846006173
-
The incretin system: Glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
-
Drucker, D.J., &, Nauck, M.A., (2006) The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet, 368, 1696-1705.
-
(2006)
Lancet
, vol.368
, pp. 1696-1705
-
-
Drucker, D.J.1
Nauck, M.A.2
-
3
-
-
0026786570
-
Gut hormones and diabetes mellitus
-
Creutzfeldt, W., &, Nauck, M., (1992) Gut hormones and diabetes mellitus. Diabetes/Metabolism Reviews, 8, 149-177.
-
(1992)
Diabetes/Metabolism Reviews
, vol.8
, pp. 149-177
-
-
Creutzfeldt, W.1
Nauck, M.2
-
4
-
-
0043169338
-
Differential effects of acute and extended infusions of glucagon-like peptide-1 on first- and second-phase insulin secretion in diabetic and nondiabetic humans
-
Quddusi, S., Vahl, T.P., Hanson, K., et al,. (2003) Differential effects of acute and extended infusions of glucagon-like peptide-1 on first- and second-phase insulin secretion in diabetic and nondiabetic humans. Diabetes Care, 26, 791-798.
-
(2003)
Diabetes Care
, vol.26
, pp. 791-798
-
-
Quddusi, S.1
Vahl, T.P.2
Hanson, K.3
-
5
-
-
0029909112
-
Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM
-
Rachman, J., Gribble, F.M., Barrow, B.A., et al,. (1996) Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM. Diabetes, 45, 1524-1530.
-
(1996)
Diabetes
, vol.45
, pp. 1524-1530
-
-
Rachman, J.1
Gribble, F.M.2
Barrow, B.A.3
-
6
-
-
0035082496
-
Glucagon-like peptide 1 increases secretory burst mass of pulsatile insulin secretion in patients with type 2 diabetes and impaired glucose tolerance
-
Ritzel, R., Schulte, M., Porksen, N., et al,. (2001) Glucagon-like peptide 1 increases secretory burst mass of pulsatile insulin secretion in patients with type 2 diabetes and impaired glucose tolerance. Diabetes, 50, 776-784.
-
(2001)
Diabetes
, vol.50
, pp. 776-784
-
-
Ritzel, R.1
Schulte, M.2
Porksen, N.3
-
7
-
-
45549101449
-
Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetes
-
Cervera, A., Wajcberg, E., Sriwijitkamol, A., et al,. (2008) Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetes. American journal of physiology. Endocrinology and metabolism, 294, E846-E852.
-
(2008)
American Journal of Physiology. Endocrinology and Metabolism
, vol.294
-
-
Cervera, A.1
Wajcberg, E.2
Sriwijitkamol, A.3
-
8
-
-
0036965113
-
The insulinotropic effect of acute exendin-4 administered to humans: Comparison of nondiabetic state to type 2 diabetes
-
Egan, J.M., Clocquet, A.R., &, Elahi, D., (2002) The insulinotropic effect of acute exendin-4 administered to humans: comparison of nondiabetic state to type 2 diabetes. Journal of Clinical Endocrinology and Metabolism, 87, 1282-1290.
-
(2002)
Journal of Clinical Endocrinology and Metabolism
, vol.87
, pp. 1282-1290
-
-
Egan, J.M.1
Clocquet, A.R.2
Elahi, D.3
-
9
-
-
27744541052
-
Exenatide augments first- and second-phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes
-
Fehse, F., Trautmann, M., Holst, J.J., et al,. (2005) Exenatide augments first- and second-phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes. Journal of Clinical Endocrinology and Metabolism, 90, 5991-5997.
-
(2005)
Journal of Clinical Endocrinology and Metabolism
, vol.90
, pp. 5991-5997
-
-
Fehse, F.1
Trautmann, M.2
Holst, J.J.3
-
10
-
-
56549107405
-
Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes
-
Linnebjerg, H., Park, S., Kothare, P.A., et al,. (2008) Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes. Regulatory Peptides, 151, 123-129.
-
(2008)
Regulatory Peptides
, vol.151
, pp. 123-129
-
-
Linnebjerg, H.1
Park, S.2
Kothare, P.A.3
-
11
-
-
53249142132
-
Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: A randomised, open-label, non-inferiority study
-
Drucker, D.J., Buse, J.B., Taylor, K., et al,. (2008) Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study. Lancet, 372, 1240-1250.
-
(2008)
Lancet
, vol.372
, pp. 1240-1250
-
-
Drucker, D.J.1
Buse, J.B.2
Taylor, K.3
-
12
-
-
34447267513
-
Efficacy and safety of incretin therapy in type 2 diabetes: Systematic review and meta-analysis
-
Amori, R.E., Lau, J., &, Pittas, A.G., (2007) Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis. JAMA, 298, 194-206.
-
(2007)
JAMA
, vol.298
, pp. 194-206
-
-
Amori, R.E.1
Lau, J.2
Pittas, A.G.3
-
13
-
-
79956336447
-
Effect of Exenatide on Splanchnic and Peripheral Glucose Metabolism in Type 2 Diabetic Subjects
-
Cersosimo, E., Gastaldelli, A., Cervera, A., et al,. (2011) Effect of Exenatide on Splanchnic and Peripheral Glucose Metabolism in Type 2 Diabetic Subjects. Journal of Clinical Endocrinology and Metabolism, 96, 1763-1770.
-
(2011)
Journal of Clinical Endocrinology and Metabolism
, vol.96
, pp. 1763-1770
-
-
Cersosimo, E.1
Gastaldelli, A.2
Cervera, A.3
-
14
-
-
80052517174
-
Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis
-
Svegliati-Baroni, G., Saccomanno, S., Rychlicki, C., et al,. (2011) Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis. Liver International, 31, 1285-1297.
-
(2011)
Liver International
, vol.31
, pp. 1285-1297
-
-
Svegliati-Baroni, G.1
Saccomanno, S.2
Rychlicki, C.3
-
15
-
-
0038497464
-
Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes
-
Kolterman, O.G., Buse, J.B., Fineman, M.S., et al,. (2003) Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes. Journal of Clinical Endocrinology and Metabolism, 88, 3082-3089.
-
(2003)
Journal of Clinical Endocrinology and Metabolism
, vol.88
, pp. 3082-3089
-
-
Kolterman, O.G.1
Buse, J.B.2
Fineman, M.S.3
-
16
-
-
33845968872
-
Mathematical modeling shows exenatide improved beta-cell function in patients with type 2 diabetes treated with metformin or metformin and a sulfonylurea
-
Mari, A., Nielsen, L.L., Nanayakkara, N., et al,. (2006) Mathematical modeling shows exenatide improved beta-cell function in patients with type 2 diabetes treated with metformin or metformin and a sulfonylurea. Hormone and Metabolic Research, 38, 838-844.
-
(2006)
Hormone and Metabolic Research
, vol.38
, pp. 838-844
-
-
Mari, A.1
Nielsen, L.L.2
Nanayakkara, N.3
-
17
-
-
51549095571
-
Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: A randomized, double-blind, placebo-controlled, parallel-group study
-
Moretto, T.J., Milton, D.R., Ridge, T.D., et al,. (2008) Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study. Clinical Therapeutics, 30, 1448-1460.
-
(2008)
Clinical Therapeutics
, vol.30
, pp. 1448-1460
-
-
Moretto, T.J.1
Milton, D.R.2
Ridge, T.D.3
-
18
-
-
0035089445
-
A model-based method for assessing insulin sensitivity from the oral glucose tolerance test
-
Mari, A., Pacini, G., Murphy, E., et al,. (2001) A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care, 24, 539-548.
-
(2001)
Diabetes Care
, vol.24
, pp. 539-548
-
-
Mari, A.1
Pacini, G.2
Murphy, E.3
-
19
-
-
0026504160
-
Estimation of insulin secretion rates from C-peptide levels Comparison of individual and standard kinetic parameters for C-peptide clearance
-
Van Cauter, E., Mestrez, F., Sturis, J., et al,. (1992) Estimation of insulin secretion rates from C-peptide levels Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes, 41, 368-377.
-
(1992)
Diabetes
, vol.41
, pp. 368-377
-
-
Van Cauter, E.1
Mestrez, F.2
Sturis, J.3
-
20
-
-
33846031943
-
Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test
-
Abdul-Ghani, M.A., Matsuda, M., Balas, B., et al,. (2007) Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care, 30, 89-94.
-
(2007)
Diabetes Care
, vol.30
, pp. 89-94
-
-
Abdul-Ghani, M.A.1
Matsuda, M.2
Balas, B.3
-
21
-
-
0942279564
-
Beta-cell dysfunction and glucose intolerance: Results from the San Antonio metabolism (SAM) study
-
Gastaldelli, A., Ferrannini, E., Miyazaki, Y., et al,. (2004) Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study. Diabetologia, 47, 31-39.
-
(2004)
Diabetologia
, vol.47
, pp. 31-39
-
-
Gastaldelli, A.1
Ferrannini, E.2
Miyazaki, Y.3
-
22
-
-
12244299450
-
Beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: A new analysis
-
Ferrannini, E., Gastaldelli, A., Miyazaki, Y., et al,. (2005) beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. Journal of Clinical Endocrinology and Metabolism, 90, 493-500.
-
(2005)
Journal of Clinical Endocrinology and Metabolism
, vol.90
, pp. 493-500
-
-
Ferrannini, E.1
Gastaldelli, A.2
Miyazaki, Y.3
-
23
-
-
33947144118
-
Thiazolidinediones improve beta-cell function in type 2 diabetic patients
-
Gastaldelli, A., Ferrannini, E., Miyazaki, Y., et al,. (2007) Thiazolidinediones improve beta-cell function in type 2 diabetic patients. American journal of physiology. Endocrinology and metabolism, 292, E871-E883.
-
(2007)
American Journal of Physiology. Endocrinology and Metabolism
, vol.292
-
-
Gastaldelli, A.1
Ferrannini, E.2
Miyazaki, Y.3
-
24
-
-
0023850277
-
Quantitative study of insulin secretion and clearance in normal and obese subjects
-
Polonsky, K.S., Given, B.D., Hirsch, L., et al,. (1988) Quantitative study of insulin secretion and clearance in normal and obese subjects. The Journal of clinical investigation, 81, 435-441.
-
(1988)
The Journal of Clinical Investigation
, vol.81
, pp. 435-441
-
-
Polonsky, K.S.1
Given, B.D.2
Hirsch, L.3
-
25
-
-
33745302884
-
The natural course of beta-cell function in nondiabetic and diabetic individuals: The Insulin Resistance Atherosclerosis Study
-
Festa, A., Williams, K., D'Agostino, R. Jr., et al,. (2006) The natural course of beta-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study. Diabetes, 55, 1114-1120.
-
(2006)
Diabetes
, vol.55
, pp. 1114-1120
-
-
Festa, A.1
Williams, K.2
D'Agostino, Jr.R.3
-
26
-
-
33845405222
-
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
-
Kahn, S.E., Haffner, S.M., Heise, M.A., et al,. (2006) Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. New England Journal of Medicine, 355, 2427-2443.
-
(2006)
New England Journal of Medicine
, vol.355
, pp. 2427-2443
-
-
Kahn, S.E.1
Haffner, S.M.2
Heise, M.A.3
-
27
-
-
77954323314
-
The stunned beta cell: A brief history
-
Ferrannini, E., (2010) The stunned beta cell: a brief history. Cell Metabolism, 11, 349-352.
-
(2010)
Cell Metabolism
, vol.11
, pp. 349-352
-
-
Ferrannini, E.1
-
28
-
-
0037045845
-
Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: A parallel-group study
-
Zander, M., Madsbad, S., Madsen, J.L., et al,. (2002) Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study. Lancet, 359, 824-830.
-
(2002)
Lancet
, vol.359
, pp. 824-830
-
-
Zander, M.1
Madsbad, S.2
Madsen, J.L.3
-
29
-
-
65949122087
-
One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: A randomized, controlled trial
-
Bunck, M.C., Diamant, M., Corner, A., et al,. (2009) One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trial. Diabetes Care, 32, 762-768.
-
(2009)
Diabetes Care
, vol.32
, pp. 762-768
-
-
Bunck, M.C.1
Diamant, M.2
Corner, A.3
-
30
-
-
31044456099
-
Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage
-
Knauf, C., Cani, P.D., Perrin, C., et al,. (2005) Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage. The Journal of clinical investigation, 115, 3554-3563.
-
(2005)
The Journal of Clinical Investigation
, vol.115
, pp. 3554-3563
-
-
Knauf, C.1
Cani, P.D.2
Perrin, C.3
-
31
-
-
50949094723
-
Arcuate glucagon-like peptide 1 receptors regulate glucose homeostasis but not food intake
-
Sandoval, D.A., Bagnol, D., Woods, S.C., et al,. (2008) Arcuate glucagon-like peptide 1 receptors regulate glucose homeostasis but not food intake. Diabetes, 57, 2046-2054.
-
(2008)
Diabetes
, vol.57
, pp. 2046-2054
-
-
Sandoval, D.A.1
Bagnol, D.2
Woods, S.C.3
-
32
-
-
4043101702
-
Separate contribution of diabetes, total fat mass, and fat topography to glucose production, gluconeogenesis, and glycogenolysis
-
Gastaldelli, A., Miyazaki, Y., Pettiti, M., et al,. (2004) Separate contribution of diabetes, total fat mass, and fat topography to glucose production, gluconeogenesis, and glycogenolysis. Journal of Clinical Endocrinology and Metabolism, 89, 3914-3921.
-
(2004)
Journal of Clinical Endocrinology and Metabolism
, vol.89
, pp. 3914-3921
-
-
Gastaldelli, A.1
Miyazaki, Y.2
Pettiti, M.3
|